Since the Court of Appeals for the Federal Circuit en banc decision in DSU Medical Corp. v. JMS Co. clarifying the requirements for inducement to infringe, proving inducement has been a challenging exercise. Nowhere is this more so than when enforcing pharmaceutical method of treatment claims against generic drug companies.
In this Webinar, our speakers will discuss the current state of the law on enforcement of pharmaceutical method of treatment claims under the Hatch-Waxman litigation scheme, and will provide useful insights into how to tackle the issues that arise in proving the active inducement and the specific intent requirements articulated by the DSU Court.
Ropes & Gray Speakers
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.